Skip to Main Content

Paper Details

Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum.
Eur Urol Oncol
5
2023
CIS, G3 component, NMIBC, Patients, Primary Papillary Ta Grade 3 Bladder Cancer, T1, T1 G3, T1 G3 carcinomas, Ta, Ta G2, Ta G2 and T1 G3 tumors, Ta G3, Ta G3 cancer, Ta G3 carcinomas, Ta G3 tumors, Ta component, Ta-T1, Ta-T1 carcinomas, bladder tumors, cancer, carcinoma in situ, non-muscle-invasive bladder cancer, patient, patients, tumor
Author NameAffiliation
Alexandre R ZlottaUniversity Health Network, Princess Margaret Cancer Center, University of Toronto
Lambertus A KiemeneyRadboud University Medical Center
James N'Dow
Theodorus H van der KwastUniversity Health Network, Princess Margaret Cancer Center, University of Toronto
  • 1 - 4

Datasets

Release 1.2